GENMAB A/S (GNMSF) — Earnings Call Analysis & IR Page

GENMAB A/S is a Healthcare company operating in Biotechnology with a $20.24B market cap.

Most recent earnings call: Q1 FY26 on May 14, 2026.

21 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.76

www.genmab.com/investor-relations

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 21 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GNMSF.

$ curl https://api.spokenalpha.com/v1/companies/GNMSF

Get an API key API docs

FAQ

Frequently asked about GNMSF

Where can I find GENMAB A/S's (GNMSF) earnings call transcripts?

Spoken Alpha indexes GNMSF's earnings call transcripts at https://spokenalpha.com/companies/GNMSF. Each call links to attributed speakers and parsed analyst Q&A. GENMAB A/S's own investor relations page is at https://www.genmab.com/investor-relations.

When was GENMAB A/S's most recent earnings call?

GENMAB A/S (GNMSF) held its most recent earnings call on 2026-05-14, covering fiscal Q1 2026.

What sector is GNMSF in?

GENMAB A/S (GNMSF) operates in the Healthcare sector (Biotechnology industry).

Overview